Abstract
The advent of antimicrobial resistance (AMR) has posed a serious challenge to the entire globe in terms of health, demonstrating the inefficiency of the existing legal, regulatory, and governance structures. With the global spread of resistant pathogens, purely national actions have not been as efficient, and hence, there is a need for coordinated international responses regarding legal measures. The instruments currently used in the world, health systems are disjointed, and none of them can support the multi-factorial drivers of resistance and its causes contained within the misuse of medicines, a poor surveillance system, unsustainable agriculture, and unequal access to quality treatment. The new legal frontier between trade, intellectual property, the environment, and public health is being constituted. This should involve enhancing binding international responsibilities and harmonizing regulatory standards, as well as increasing accountability tools. Legal means may also be used to achieve cross-sectoral cooperation so as to bring the human health policy, veterinary policy, agricultural policy, and environmental policy to the same level. In addition to this, international cooperation must maintain a balance between the motive of innovation and equal access to the antimicrobials. Such measures as the promotion of enforceable and comprehensive legal strategies can also make the international community more effective in containing AMR and protecting the effectiveness of life-saving treatments in the long term.